Participants with the diagnosis of early Parkinson 's disease on a stable regimen of 1 mg/day rasagiline or 10 mg/day selegiline were randomly assigned ( 1:1:1 ) to 15 mg/day pioglitazone , 45 mg/day pioglitazone , or placebo .